Table 1.
Immunoregulatory factors of myxoma virus
Category | MYXV gene product | Function | Therapeutic implications |
---|---|---|---|
PKR signaling related | M156 | A structural homolog of cellular eIF2α and a viral pseudosubstrate for PKR | Not tested |
M029 | Truncated homolog of VACV E3, a PKR inhibitor | Not tested | |
Viroceptors | M-T2 | A rabbit-specific TNF viroceptor | Not tested |
M-T7 |
|
|
|
M-T1 | A species-nonspecific viroceptor for chemokines of CC subfamily through C-terminal consensus domain | M-T1 can inhibit immune cell infiltration into damaged tissue and can prevent transplant failure. | |
Serine protease inhibitors (Serpins) | SERP-1 | A broad spectrum protease inhibitor in a species non-specific manner | Purified SERP-1 inhibits inflammatory cascades and has undergone clinical trial for acute myocardial syndrome. |
Intracellular immunoregulatory factors | M135 | A virulence factor in rabbit pathogenesis of myxoma virus. Expressed on the cell surface during infection but its function is still unknown. | Myxoma virus with M135R gene knockout exhibits improved oncolysis for human glioma cancer cells in vitro. |
M013 | In human monoctyes, M013 binds to ASC-1 and NFκB1 to inhibit inflammasome activation and NFκB signaling. | Not tested | |
M130 | A virulence factor with unknown function | Not tested | |
M153 |
|
Not tested. | |
Mimicry of cell surface immune recognition molecules | M128 (vCD47) | A cell surface inhibitor of macrophage activation with unknown mechanism | Not tested |
M141 (vCD200) |
|
Not tested | |
Others | M063 | MYXV with M063R gene knockout loses the ability to infect rabbits. M063 is a rabbit-specific host range factor of unknown function. | M063R knockout MYXV has been shown to have superior oncolytic effect to human glioma cancer cells in vitro. |